James Carthew: don’t let Biopharma’s slow start give you the wrong impression
Biopharma Credit, the biggest of this year’s investment trust launches, signifies the maturation of the biotechnology sector, even if it has yet to make any investments.
- Citywire launches inaugural Investment Trust Awards 6
- Daniel Koller: biotech is heading for another blockbuster year
- James Carthew: there is a future for quality ‘zeros’ 2
- Trusts take oh-so teeny-weeny steps to cut charges 1
- Cheap platforms for buy-and-hold investment trust investors 19
- James Carthew: don’t let Biopharma’s slow start give you the wrong impression 2